Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer
![](/xmlui/themes/Mirage2//images/mime.png)
Erişim
info:eu-repo/semantics/closedAccessTarih
2016Yazar
Salman, TarıkBilici, Ahmet
Arslan, Çağatay
Varol, Umut
Yıldız, İbrahim
Akyol, Murat
Yıldız, Yaşar
Küçükzeybek, Yüksel
Alacacıoğlu, Ahmet
Yılmaz, Uğur
Üst veri
Tüm öğe kaydını gösterKünye
Salman, T., Bilici, A., Arslan, Ç., Varol, U., Yıldız, İ., Akyol, M. ... Yılmaz, U. (2016). Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Gastrointestinal Cancers Symposium. San Francisco, California, January 21-23, 2016. https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615Özet
...
WoS Q Kategorisi
Q1Kaynak
Gastrointestinal Cancers SymposiumCilt
34Sayı
4Bağlantı
https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615https://hdl.handle.net/20.500.12511/5719
Koleksiyonlar
- Bildiri Koleksiyonu [516]
- WoS İndeksli Yayınlar Koleksiyonu [6677]